Andromeda Biotech andromedabio.com


Public lists: Pharma Startups (4732)

Andromeda Biotech is focused on the development of an innovative treatment for autoimmune diabetes. The company's lead product, DiaPep277 is currently in Phase III clinical trials for treating type 1 diabetes (T1D). DiaPep277 is a unique peptide representing a novel therapeutic approach to prevent the destruction of insulin producing cells in the pancreas.

Andromeda Biotech is focused on the development of an innovative treatment for autoimmune diabetes. The company's lead product, DiaPep277 is currently in Phase III clinical trials for treating type 1 diabetes (T1D). DiaPep277 is a unique peptide repr...Show all

Company (Alive / Active)

Phone:

Fax:




Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Andromeda Biotech $0M Jun 14, 2007

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Andromeda Biotech Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Clal Biotechnology IndustriesVenture CapitalRamat Gan, IsraelUnattributed VC
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Hsp therapy in conjunction with a low antigenicity diet Feb 15, 2012 Sep 09, 2014 Patent
Hsp peptides and analogs for modulation of immune responses via antigen presenting cells Jul 30, 2004 Aug 18, 2009 Patent